Journal of Cancer Research and Therapeutics Close
 

Figure 2: Contrast agent enhanced MRI from a patient with uterine fibroids. (a) Pre-treatment image shows the fibroid with enhancement. (b) One month post-treatment, MRI shows the fibroid shrank with no enhancement. This patient was treated with Haifu® JM focused ultrasound tumor therapeutic system (JM2.5C, Chongqing Haifu Technology Co., Ltd., China), in combination with a 1.5-Tesla MRI system (Symphony, Siemens, Germany), which provides real-time guidance and control

Figure 2: Contrast agent enhanced MRI from a patient with uterine fibroids. (a) Pre-treatment image shows the fibroid with enhancement. (b) One month post-treatment, MRI shows the fibroid shrank with no enhancement. This patient was treated with Haifu® JM focused ultrasound tumor therapeutic system (JM2.5C, Chongqing Haifu Technology Co., Ltd., China), in combination with a 1.5-Tesla MRI system (Symphony, Siemens, Germany), which provides real-time guidance and control